Understanding AMDHD1: A Protein Involved in Cellular Processes

Target Name: AMDHD1

NCBI ID: G144193

AMDHD1

Understanding AMDHD1: A Protein Involved in Cellular Processes

AMDHD1 (Amidohydrolase domain-containing protein 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of enzymes known as hydrolases, which are a group of proteins that are involved in the breakdown of various types of macromolecules, including proteins, nucleic acids, and carbohydrates.

One of the unique features of AMDHD1 is its structure. It consists of a single polypeptide chain that is composed of 21 amino acid residues. The protein has a distinct N-terminus that is involved in its catalytic activity, as well as a C-terminus that is involved in its stability and localization in the cell.

AMDHD1 is involved in a variety of cellular processes that are important for proper tissue function and development. One of its main functions is the breakdown of carbohydrates, which is a critical step in the metabolism of the cell. AMDHD1 is also involved in the regulation of various cellular processes, including cell signaling, cell division, and inflammation.

In addition to its role in cellular metabolism, AMDHD1 is also a potential drug target. Its unique structure and the fact that it is expressed in a variety of tissues make it an attractive target for small molecule inhibitors. Several studies have shown that AMDHD1 is sensitive to inhibitors such as benzodiazepines, a class of drugs that are commonly used to treat anxiety and insomnia.

Another potential application of AMDHD1 as a drug target is its role in the development of certain diseases. The breakdown of carbohydrates is a critical step in the development of certain diseases, such as diabetes, cancer, and neurodegenerative diseases. By inhibiting the activity of AMDHD1, it may be possible to treat these diseases and improve the quality of life for patients.

In addition to its potential as a drug target, AMDHD1 is also a potential biomarker. Its unique structure and the fact that it is expressed in a variety of tissues make it an attractive candidate for diagnostic studies. Several studies have shown that AMDHD1 is expressed in a variety of tissues and that its levels are sensitive to various factors, including diabetes, hypertension, and certain medications.

Overall, AMDHD1 is a protein that is involved in a variety of cellular processes that are important for proper tissue function and development. Its unique structure and its expression in a variety of tissues make it an attractive target for small molecule inhibitors, and its potential as a drug and biomarker make it a valuable tool for the study of these processes. Further research is needed to fully understand the role of AMDHD1 in cellular biology and its potential as a drug and biomarker.

Protein Name: Amidohydrolase Domain Containing 1

The "AMDHD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AMDHD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets